Rafferty Asset Management, LLC Precision Biosciences Inc Transaction History

Rafferty Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.96 - $7.76 $476,613 - $1.25 Million	-161,018 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$7.4 - $11.66 $566,329 - $892,351	76,531 Added 90.58%	161,018 $1.19 Million
Q3 2021 Nov 10, 2021	SELL	$9.18 - $14.15 $161,852 - $249,478	-17,631 Reduced 17.27%	84,487 $975,000
Q2 2021 Aug 10, 2021	SELL	$8.07 - $12.52 $1.46 Million - $2.26 Million	-180,762 Reduced 63.9%	102,118 $1.28 Million
Q1 2021 May 10, 2021	BUY	$8.57 - $15.79 $2.21 Million - $4.07 Million	257,959 Added 1035.11%	282,880 $2.93 Million
Q4 2020 Feb 10, 2021	BUY	$5.98 - $12.47 $149,027 - $310,764	24,921 New	24,921 $208,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $791M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.